Skip to main content
Top
Published in: Urolithiasis 3/2012

01-06-2012 | Original Paper

Updated epidemiologic study of urolithiasis in Turkey II: role of metabolic syndrome components on urolithiasis

Authors: Murat Binbay, Emrah Yuruk, Tolga Akman, Erhan Sari, Ozgur Yazici, İbrahim Mesut Ugurlu, Yalcın Berberoglu, Ahmet Yaser Muslumanoglu

Published in: Urolithiasis | Issue 3/2012

Login to get access

Abstract

The components of metabolic syndrome, such as obesity, hypertension, and diabetes, are thought to be associated with urolithiasis. However, there are few large-scale studies that have examined the association between metabolic syndrome and urolithiasis, which prompted us to study and evaluate the relationship between metabolic syndrome components and urolithiasis in a nationwide survey, using the cross-sectional study conducted by a professional investigation company, with 2,468 enrolled participants, aged between 18 and 70 years, from 33 provinces in Turkey. Participants were interviewed face-to-face by medical faculty students. Participants with a history of urolithiasis (Group 1) were compared with participants without a history of urolithiasis (Group 2) in terms of hypertension, diabetes, body-mass index (BMI), waist size, and trouser size using Chi-square and odds ratio tests. Of the 2,468 participants, 274 (11.1%) reported a history of urinary stone disease diagnosed by a physician. The percentage of participants with hypertension along with urolithiasis was significantly higher than that in participants without urolithiasis (16.9 and 34.3%, p 0.000, OR 3.0). The percentage of participants with diabetes in groups 1 and 2 was 14.2 and 9%, respectively (p 0.001, OR 1.83). The mean BMI was 27.2 and 25.2, respectively (p 0.01). Participants with a BMI >30 had a 2.2-fold increased risk of having urolithiasis. The mean waist size was significantly greater in participants with urolithiasis (p 0.000). Those with a waist size >100 cm had a 1.87-fold increased risk of having urolithiasis. The mean trouser size was also significantly larger in those participants who were stone formers (p 0.003). The results indicate that metabolic syndrome components are important factors in the development of urolithiasis.
Literature
2.
go back to reference Pearle M, Calhoun E, Curhan GC (2004) National institute of diabetes and digestive and kidney diseases. urolithiasis. In: Litwin MS, Saigal CS (eds) Urologic diseases in America. US Dept of Health and Human Services, Washington, DC, p 34 Pearle M, Calhoun E, Curhan GC (2004) National institute of diabetes and digestive and kidney diseases. urolithiasis. In: Litwin MS, Saigal CS (eds) Urologic diseases in America. US Dept of Health and Human Services, Washington, DC, p 34
3.
go back to reference Lingeman JE, Saywell RM Jr, Woods Jr, Newman DM (1986) Cost analysis of extracorporeal shock wave lithotripsy relative to other surgical and nonsurgical treatment alternatives for urolithiasis. Med Care 24:1151–1160PubMedCrossRef Lingeman JE, Saywell RM Jr, Woods Jr, Newman DM (1986) Cost analysis of extracorporeal shock wave lithotripsy relative to other surgical and nonsurgical treatment alternatives for urolithiasis. Med Care 24:1151–1160PubMedCrossRef
4.
go back to reference Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef
5.
go back to reference Hesse A, Brandle E, Wilbert D et al (2000) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713CrossRef Hesse A, Brandle E, Wilbert D et al (2000) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713CrossRef
6.
go back to reference Mokdad AH, Bowman BA, Ford ES et al (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286(10):195–200CrossRef Mokdad AH, Bowman BA, Ford ES et al (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286(10):195–200CrossRef
7.
go back to reference Ford ES, Giles WH, Dietz WH (2000) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 16(287):356–359 Ford ES, Giles WH, Dietz WH (2000) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 16(287):356–359
9.
go back to reference Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140:167–174PubMed Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140:167–174PubMed
10.
go back to reference Leoncini G, Ratto E, Viazzi F et al (2005) Metabolic syndrome is associated with early signs of organ damage in non diabetic, hypertensive patients. J Intern Med 257:454–460PubMedCrossRef Leoncini G, Ratto E, Viazzi F et al (2005) Metabolic syndrome is associated with early signs of organ damage in non diabetic, hypertensive patients. J Intern Med 257:454–460PubMedCrossRef
11.
go back to reference Locatelli F, Pozzoni P, Del Vecchio L (2006) Renal manifestations in the metabolic syndrome. J Am Soc Nephrol 17:S81–S85PubMedCrossRef Locatelli F, Pozzoni P, Del Vecchio L (2006) Renal manifestations in the metabolic syndrome. J Am Soc Nephrol 17:S81–S85PubMedCrossRef
12.
go back to reference Klausen KP, Parving HH, Scharling H et al (2007) The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 262:470–478PubMedCrossRef Klausen KP, Parving HH, Scharling H et al (2007) The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 262:470–478PubMedCrossRef
13.
go back to reference Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392PubMedCrossRef Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392PubMedCrossRef
14.
go back to reference Pak CY, Sakhaee K, Moe O, Preminger GM, Poindexter JR, Peterson RD, Pietrow P, Ekeruo W (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523–527PubMedCrossRef Pak CY, Sakhaee K, Moe O, Preminger GM, Poindexter JR, Peterson RD, Pietrow P, Ekeruo W (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523–527PubMedCrossRef
15.
go back to reference Muslumanoglu AY, Binbay M, Yuruk E et al (2011) Updated epidemiologic study of urolithiasis in Turkey I: changing characteristics of urolithiasis. Urol Res 39:309–314PubMedCrossRef Muslumanoglu AY, Binbay M, Yuruk E et al (2011) Updated epidemiologic study of urolithiasis in Turkey I: changing characteristics of urolithiasis. Urol Res 39:309–314PubMedCrossRef
16.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef
17.
go back to reference Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed
18.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef
19.
go back to reference Sarıca K, Altay B, Erturhan S (2008) Effect of being overweight on stone forming risk factors. Urology 71:771–774PubMedCrossRef Sarıca K, Altay B, Erturhan S (2008) Effect of being overweight on stone forming risk factors. Urology 71:771–774PubMedCrossRef
20.
go back to reference Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172:159–163PubMedCrossRef Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172:159–163PubMedCrossRef
21.
go back to reference Siener R, Glatz S, Nicolay C, Hesse A (2004) The role of owerweight and obestiy in calcium oxalate stone formation. Obes Res 12:106–113PubMedCrossRef Siener R, Glatz S, Nicolay C, Hesse A (2004) The role of owerweight and obestiy in calcium oxalate stone formation. Obes Res 12:106–113PubMedCrossRef
22.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235PubMedCrossRef
23.
go back to reference Meydan N, Barutca S, Caliskan S, Camsari T (2003) Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 37:64–70PubMedCrossRef Meydan N, Barutca S, Caliskan S, Camsari T (2003) Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 37:64–70PubMedCrossRef
24.
go back to reference Lieske JC, de la Vega LS, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ 3rd, Leibson CL (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 48:897–904PubMedCrossRef Lieske JC, de la Vega LS, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ 3rd, Leibson CL (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 48:897–904PubMedCrossRef
25.
go back to reference Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033PubMedCrossRef Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033PubMedCrossRef
26.
go back to reference Tibblin G (1967) High blood pressure in men aged 50- a population study of men born in 1913. Acta Med Scand Suppl 470:1–84PubMed Tibblin G (1967) High blood pressure in men aged 50- a population study of men born in 1913. Acta Med Scand Suppl 470:1–84PubMed
27.
go back to reference Cappuccio FB, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical associaiton. BMJ 300:1234–1236PubMedCrossRef Cappuccio FB, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical associaiton. BMJ 300:1234–1236PubMedCrossRef
28.
go back to reference Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A (1999) Essential arteria hypertension and stone disease. Kidney Int 17:1017–1022 Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A (1999) Essential arteria hypertension and stone disease. Kidney Int 17:1017–1022
29.
go back to reference Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46:263–269PubMedCrossRef Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46:263–269PubMedCrossRef
30.
go back to reference Battle DC, Sharma AM, Alsheika MW et al (1993) Renal asid excretion and intracellular pH in salt-sensitive genetic hypertension. J Clin Invest 91:2178–2184CrossRef Battle DC, Sharma AM, Alsheika MW et al (1993) Renal asid excretion and intracellular pH in salt-sensitive genetic hypertension. J Clin Invest 91:2178–2184CrossRef
31.
go back to reference Eisner BH, Porten SP, Bechis SK et al (2010) Hypertension is associated with increased urinary calcium excretion in patients with urolithiasis. J Urol 183:576–579PubMedCrossRef Eisner BH, Porten SP, Bechis SK et al (2010) Hypertension is associated with increased urinary calcium excretion in patients with urolithiasis. J Urol 183:576–579PubMedCrossRef
32.
go back to reference Madore F, Stampfer Mj, Rimm EB, Curhan GC (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46–53PubMedCrossRef Madore F, Stampfer Mj, Rimm EB, Curhan GC (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46–53PubMedCrossRef
Metadata
Title
Updated epidemiologic study of urolithiasis in Turkey II: role of metabolic syndrome components on urolithiasis
Authors
Murat Binbay
Emrah Yuruk
Tolga Akman
Erhan Sari
Ozgur Yazici
İbrahim Mesut Ugurlu
Yalcın Berberoglu
Ahmet Yaser Muslumanoglu
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 3/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0447-x

Other articles of this Issue 3/2012

Urolithiasis 3/2012 Go to the issue